Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2018 06:50 ET | Source: Genmab A/S

Genmab Announces 2017 Net Sales Figures for DARZALEX® (Daratumumab)

Company Announcement Net sales of DARZALEX in 2017 totaled USD 1,242 million Genmab receives royalties on worldwide sales from Janssen Biotech, Inc. Copenhagen,...
January 22, 2018 02:06 ET | Source: Genmab A/S

Genmab Announces Novartis’ Intention to Transition Arzerra® (ofatumumab) from Commercial Availability to Limited Availability via Compassionate Use Programs for the Treatment of CLL in Non-US Markets

Company Announcement Novartis intends to transition the commercial availability of Arzerra to limited availability via compassionate use programs for treatment of CLL in non-US markets....
January 19, 2018 17:27 ET | Source: Genmab A/S

U.S. FDA Grants Priority Review for Daratumumab in Front Line Multiple Myeloma

Company Announcement U.S. FDA grants Priority Review to daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma...
January 09, 2018 14:58 ET | Source: Genmab A/S

Major Shareholder Announcement

Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; January 9, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 29 of the...
January 02, 2018 09:16 ET | Source: Genmab A/S

Genmab to Present at the 36th Annual J.P. Morgan Healthcare Conference

Media Release Copenhagen, Denmark; January 2, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 36th Annual...
December 21, 2017 08:27 ET | Source: Genmab A/S

Selskabsvedtægter for Genmab A/S

Selskabsvedtægter for Genmab A/S dateret den 15. december 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
December 21, 2017 08:27 ET | Source: Genmab A/S

Articles of Association for Genmab A/S

Genmab A/S has published its Articles of Association dated December 15, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm Contact: Rachel...
December 15, 2017 13:52 ET | Source: Genmab A/S

Grant of Restricted Stock Units to Board Members, Management and Employees and Grant of Warrants to Management and Employees in Genmab

Company Announcement Copenhagen, Denmark; December 15, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 49,680 restricted stock units...
December 11, 2017 06:39 ET | Source: Genmab A/S

Genmab’s 2017 R&D Update

Media Release R&D Update to be held today in Atlanta, Georgia Key Opinion Leaders to discuss daratumumab and tisotumab vedotin data Discussion of Genmab’s pipeline, 2017 progress...
December 04, 2017 11:01 ET | Source: Genmab A/S

Genmab to Hold 2017 R&D Update

Media Release R&D Update to be held live in Atlanta, Georgia Key Opinion Leaders to discuss daratumumab and tisotumab vedotin data Discussion of Genmab’s pipeline, 2017 progress...